Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|August 10, 2016
Amino acid amides of piperic acid (PA) and 4-ethylpiperic acid (EPA) as NorA efflux pump inhibitors of Staphylococcus aureusNaiem Ahmad Wani, Samsher Singh, Saleem Farooq, et al.
Diabetes Care|August 29, 2006
Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes: the Early Diabetes Intervention ProgramM Sue Kirkman, R Ravi Shankar, Sudha Shankar, et al.
Macromolecular Bioscience|July 15, 2026
Enhancing the Antimicrobial Potency of Self-Assembling Antibiotics by Co-Assembly-Based Aggregation ModulationBodhisattwa Das Gupta, Rahul Kuiri, Thangavel Vijayakanth, et al.
The Biochemical Journal|March 24, 2020
A nonpeptidyl molecule modulates apoptosis-like cell death by inhibiting P. falciparum metacaspase-2Vandana, Sudha Shankar, Kona Madhavinadha Prasad, et al.
Bioconjugate Chemistry|December 9, 2017
Cyclodipeptide c(Orn-Pro) Conjugate with 4-Ethylpiperic Acid Abrogates Cancer Cell Metastasis through Modulating MDM2Sudha Shankar, Mir Mohd Faheem, Debasis Nayak, et al.
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placeboMargaret O Sowell, Nitai Mukhopadhyay, Patrizia Cavazzoni, et al.
Journal of the American Society for Mass Spectrometry|October 9, 2025
LCMS/MS-Based Mining of the Peptaibiome: A Discovery of New PeptaibolsNisha Sharma, Poonam Choudhary, Priya Kumari, et al.
ACS Medicinal Chemistry Letters|October 22, 2015
Inhibition of Invasion in Pancreatic Cancer Cells by Conjugate of EPA with β(3,3)-Pip-OH via PI3K/Akt/NF-kB PathwayHina Amin, Naiem Ahmad Wani, Saleem Farooq, et al.
Diabetes, Obesity & Metabolism|April 4, 2017
Treatment with LY2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetesCristina B Guzman, Xiaotian M Zhang, Rong Liu, et al.
Cardiovascular Toxicology|September 17, 2004
Changes in thrombolytic and inflammatory markers after initiation of indinavir- or amprenavir-based antiretroviral therapyErika M Young, Robert V Considine, Fred R Sattler, et al.
Pageof 3